Inflammation and Insulin Resistance in a Group of Sub-Saharan African Women with Polycystic Ovary Syndrome

References

• Khan KA, Stas S, Kurukulasuriya LR. Polycystic ovarian syndrome. J Cardiometab Syndr. 2006;1(2):125–130. doi:10.1111/j.1559-4564.2006.05675.x
   PubMedGoogle Scholar
• Bozdag G, Mumusoglu S, Zengin D, Karabulut E, Yildiz BO. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod. 2016;31(12):2841–2855. doi:10.1093/humrep/dew218
   PubMed Web of Science ®Google Scholar
• Azziz R, Adashi EY. Stein and Leventhal: 80 years on. Am J Obstet Gynecol. 2016;214(2):247–e1.
   PubMed Web of Science ®Google Scholar
• Cussons AJ, Watts GF, Burke V, Shaw JE, Zimmet PZ, Stuckey BGA. Cardiometabolic risk in polycystic ovary syndrome: a comparison of different approaches to defining the metabolic syndrome. Hum Reprod. 2008;23(10):2352–2358. doi:10.1093/humrep/den263
   PubMed Web of Science ®Google Scholar
• Azziz R, Carmina E, Dewailly D, et al. The androgen excess and PCOS society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2009;91(2):456–488.
   PubMed Web of Science ®Google Scholar
• Popovic M, Sartorius G, Christ-Crain M. Chronic low-grade inflammation in polycystic ovary syndrome: is there a (patho)-physiological role for interleukin-1? Semin Immunopathol. 2019;41(4):447–459. doi:10.1007/s00281-019-00737-4
   PubMed Web of Science ®Google Scholar
• González F. Inflammation in polycystic ovary syndrome: underpinning of insulin resistance and ovarian dysfunction. Steroids. 2012;77(4):300–305. doi:10.1016/j.steroids.2011.12.003
   PubMed Web of Science ®Google Scholar
• Sharma P. Inflammation and the metabolic syndrome. Indian J Clin Biochem. 2011;26(4):317–318. doi:10.1007/s12291-011-0175-6
   PubMedGoogle Scholar
• Rudnicka E, Kunicki M, Suchta K, Machura P, Grymowicz M, Smolarczyk R. Inflammatory markers in women with polycystic ovary syndrome. Biomed Res Int. 2020;2020:1–10. doi:10.1155/2020/4092470
   Web of Science ®Google Scholar
• Duleba AJ, Dokras A. Is PCOS an inflammatory process? Fertil Steril. 2012;97(1):7–12. doi:10.1016/j.fertnstert.2011.11.023
   PubMed Web of Science ®Google Scholar
• Koppalli S, Vivekananda RB, Vijayaraghavan R, Paluru R, Rangarao T, Sarma SSB. Evaluation of serum hs-CRP concentrations in reproductive women with polycystic ovarian syndrome (PCOS). Biomed Res. 2017;28(5).
   Google Scholar
• Kelly CCJ, Lyall H, Petrie JR, Gould GW, Connell JMC, Sattar N. Low grade chronic inflammation in women with polycystic ovarian syndrome. J Clin Endocrinol Metab. 2001;86(6):2453–2455. doi:10.1210/jcem.86.6.7580
   PubMed Web of Science ®Google Scholar
• Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19–25. doi:10.1016/j.fertnstert.2003.10.004
   Web of Science ®Google Scholar
• Pacini G, Mari A. Methods for clinical assessment of insulin sensitivity and β-cell function. Best Pract Res Clin Endocrinol Metab. 2003;17(3):305–322. doi:10.1016/S1521-690X(03)00042-3
   PubMed Web of Science ®Google Scholar
• Charan J, Biswas T. How to calculate sample size for different study designs in medical research? Indian J Psychol Med. 2013;35(2):121–126. doi:10.4103/0253-7176.116232
   PubMedGoogle Scholar
• Hu W, Qiao J, Yang Y, Wang L, Li R. Elevated C-reactive protein and monocyte chemoattractant protein-1 in patients with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol. 2011;157(1):53–56. doi:10.1016/j.ejogrb.2011.03.015
   PubMed Web of Science ®Google Scholar
• Escobar-Morreale HF, Luque-Ramírez M, González F. Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis. Fertil Steril. 2010;95(3):1048–1058.
   PubMed Web of Science ®Google Scholar
• Boulman N, Levy Y, Leiba R, et al. Increased C-reactive protein levels in the polycystic ovary syndrome: a marker of cardiovascular disease. J Clin Endocrinol Metab. 2004;89(5):2160–2165. doi:10.1210/jc.2003-031096
   PubMed Web of Science ®Google Scholar
• Wisse BE. The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol. 2004;15(11):2792–2800. doi:10.1097/01.ASN.0000141966.69934.21
   PubMed Web of Science ®Google Scholar
• Spritzer PM, Lecke SB, Satler F, Morsch DM. Adipose tissue dysfunction, adipokines, and low-grade chronic inflammation in polycystic ovary syndrome. Reproduction. 2015;149(5):R219–R227. doi:10.1530/REP-14-0435
   PubMed Web of Science ®Google Scholar
• Souza Dos Santos AC, Soares NP, Costa EC, de Sá JCF, Azevedo GD, Lemos TMAM. The impact of body mass on inflammatory markers and insulin resistance in polycystic ovary syndrome. Gynecol Endocrinol. 2015;31(3):225–228. doi:10.3109/09513590.2014.976546
   PubMed Web of Science ®Google Scholar
• Black S, Kushner I, Samols D. C-reactive protein. J Biol Chem. 2004;279(47):48487–48490. doi:10.1074/jbc.R400025200
   PubMed Web of Science ®Google Scholar
• Doh E, Mbanya A, Kemfang-Ngowa JD, et al. The relationship between adiposity and insulin sensitivity in African women living with the polycystic ovarian syndrome: a Clamp Study. Int J Endocrinol. 2016;2016:1–6. doi:10.1155/2016/9201701
   Web of Science ®Google Scholar
• Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev. 1997;18(6):774–800.
   PubMed Web of Science ®Google Scholar
• Nestler JE, Jakubowicz DJ, de Vargas AF, Brik C, Quintero N, Medina F. Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system. J Clin Endocrinol Metab. 1998;83(6):2001–2005.
   PubMed Web of Science ®Google Scholar
• Willis DS, Watson H, Mason HD, Galea R, Brincat M, Franks S. Premature response to luteinizing hormone of granulosa cells from anovulatory women with polycystic ovary syndrome: relevance to mechanism of anovulation. None. 1998;83(11):3984–3991.
   Google Scholar
• Franik G, Bizoń A, Włoch S, et al. The effect of abdominal obesity in patients with polycystic ovary syndrome on metabolic parameters. Eur Rev Med Pharmacol Sci. 2017;21(21):4755–4761.
   PubMed Web of Science ®Google Scholar
• Lisko I, Tiainen K, Stenholm S, et al. Inflammation, adiposity, and mortality in the oldest old. Rejuvenation Res. 2012;15(5):445–452. doi:10.1089/rej.2011.1310
   PubMed Web of Science ®Google Scholar
• Goswami S, Choudhuri S, Bhattacharya B, et al. Chronic inflammation in polycystic ovary syndrome: a case–control study using multiple markers. Int J Reprod Biomed. 2021;19(4):313–320.
   PubMed Web of Science ®Google Scholar
• Ganie MA, Hassan S, Nisar S, et al. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS). Gynecol Endocrinol. 2014;30(11):781–784. doi:10.3109/09513590.2014.924099
   PubMed Web of Science ®Google Scholar
• Yavasoglu I, Kucuk M, Cildag B, Arslan E, Gok M, Kafkas S. A novel association between polycystic ovary syndrome and Helicobacter pylori. Am J Med Sci. 2009;338(3):174–177. doi:10.1097/MAJ.0b013e3181a63c8a
   PubMed Web of Science ®Google Scholar
• Morin-Papunen LC, Duleba AJ, Bloigu A, Järvelin M-R, Saikku P, Pouta A. Chlamydia antibodies and self-reported symptoms of oligo-amenorrhea and hirsutism: a new etiologic factor in polycystic ovary syndrome? Fertil Steril. 2010;94(5):1799–1804. doi:10.1016/j.fertnstert.2009.10.021
   PubMed Web of Science ®Google Scholar
• Dursun E, Akalın FA, Güncü GN, et al. Periodontal disease in polycystic ovary syndrome. Fertil Steril. 2011;95(1):320–323. doi:10.1016/j.fertnstert.2010.07.1052
   PubMed Web of Science ®Google Scholar
• Essome MCN, Nsawir BJ, Nana RD, Molu P, Mohamadou M. Etude séro-epidémiologique de trois infections sexuellement transmissibles (Chlamydia Trachomatis, Hépatite B, Syphilis): cas de l’Hôpital de District de Nkoldongo à Yaoundé. Pan Afr Med J. 2016;25:244. doi:10.11604/pamj.2016.25.244.11107
   Google Scholar
• Milan-Mattos JC, Anibal FF, Perseguini NM, et al. Effects of natural aging and gender on pro-inflammatory markers. Braz J Med Biol Res. 2019;52(9). doi:10.1590/1414-431x20198392
   PubMed Web of Science ®Google Scholar
• Monteiro R, Azevedo I. Chronic inflammation in obesity and the metabolic syndrome. Mediators Inflamm. 2010;2010:1–10. doi:10.1155/2010/289645
   Web of Science ®Google Scholar
• Wallace TM, Matthews DR. The assessment of insulin resistance in man. Diabet Med. 2002;19(7):527–534. doi:10.1046/j.1464-5491.2002.00745.x
   PubMed Web of Science ®Google Scholar
• Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–419. doi:10.1007/BF00280883
   PubMed Web of Science ®Google Scholar
• Goodyear MDE, Krleza-Jeric K, Lemmens T. The declaration of Helsinki. BMJ. 2007;335(7621):624–625. doi:10.1136/bmj.39339.610000.BE
   PubMed Web of Science ®Google Scholar